by James on 23 February 2008
Back in early 2006 I wrote about a new class of migraine drugs that was in the testing phases. It’s called a gap junction blocker, and the drug being tested is called tonabersat. It’s time for an update!
A major phase of the clinical trials have been completed for tonabersat. The results were encouraging, and reason [...]
by James on 16 January 2006
Testing is proceeding on a new migraine drug. I know, you hear that all the time – but this one is a little different. It’s a new type of drug, called a gap junction blocker. Gap junctions are important – everybody has them. They’re like little highways (or junctions) between your cells. Along those highways [...]